文献速递免疫规划传染病防控与疫情报告

猪圆环病毒相关疾病对田间猪场猪瘟活疫苗效力的影响

The impact of porcine circovirus associated diseases on live attenuated classical swine fever vaccine in field farm applications.
PubMed 文献 · Vaccine · 2019-09-06

研究在常规猪场开展免疫攻毒试验,评价PCV2亚单位疫苗效力及其对猪瘟活疫苗的影响。免疫猪病毒载量更低、淋巴结抗原染色更少、平均日增重更高,但攻毒后仍检出低水平PCV2感染。PCV2感染可损害猪瘟活疫苗诱导的中和抗体应答,尤其当血清PCV2载量大于10² copies/mL时。

要点

  • PCV2亚单位疫苗可降低病毒载量并改善增重,但不能根除病毒。
  • PCV2感染期间猪瘟活疫苗诱导的中和抗体应答受损。
  • 血清PCV2载量大于10² copies/mL可能损害猪瘟疫苗效力。

核心结论

  • PCV2亚单位疫苗在田间猪场具有保护效力但无法根除病毒,导致亚临床感染增加。
  • PCV2亚临床或系统性疾病可损害猪瘟活疫苗诱导的中和抗体应答,影响其田间应用效力。

研究设计与样本

  • 采用常规猪进行PCV2亚单位疫苗免疫后攻毒试验,并进一步研究PCV2感染对猪瘟活疫苗的影响。
  • 对PCV2亚临床感染猪进行猪瘟病毒中和抗体滴度的长期监测,并尽量降低母源抗体干扰。

主要发现

  • 免疫猪血清病毒载量更低、淋巴结病毒抗原染色更少、平均日增重更高。
  • 攻毒后免疫猪仍检出低水平PCV2感染,提示疫苗不能根除病毒。
  • PCV2系统性疾病与亚临床感染猪的猪瘟病毒中和抗体水平无差异。
  • 血清PCV2载量大于10² copies/mL可能损害猪瘟疫苗效力。

关键数值与推荐

  • 血清PCV2载量大于10² copies/mL可能损害猪瘟活疫苗效力。

临床怎么用

  • 在PCV2感染活跃猪场,应关注猪瘟活疫苗免疫效果,必要时监测猪瘟中和抗体。
  • 控制PCV2亚临床感染有助于维持猪瘟疫苗诱导的免疫应答。

局限性

  • 研究基于常规猪模型和田间试验,结论外推需谨慎。
  • 原文未报告样本量、置信区间及P值等统计细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Porcine circovirus associated diseases (PCVADs) are among the most important diseases affecting the worldwide swine industry. Vaccination against porcine circovirus type 2 (PCV2) infection has been utilized for disease control and effectively reduces clinical signs of PCVADs. To evaluate the efficacy of the PCV2 vaccine in field farms, we conducted a trial using conventional pigs immunized with the subunit PCV2 vaccine followed by PCV2 challenge. Immunized pigs demonstrated lower serum viral loads, less viral antigen staining in lymph nodes, and higher average daily weight gain, confirming the protective efficacy of the vaccine. However, low levels of PCV2 infection were still detected in vaccinated pigs after challenge, suggesting that the PCV2 vaccine was unable to eradicate the virus, which could lead to asymptomatic PCV2 subclinical infection (PCV2-SI) in pig farms. Additionally, PCV2 infection is a risk factor for impaired pig immune response development during the weaning to growth stages, which is a crucial period to receive vaccines against classical swine fever (CSF). Therefore, the impact of PCV2-SI or PCV2-systemic disease (PCV2-SD) on live attenuated CSF vaccine was investigated. After PCV2 challenge, there was no difference in levels of classical swine fever virus (CSFV) neutralizing antibodies (NA) between pigs with PCV2-SD and PCV2-SI, suggesting that the efficacy of CSF vaccine was compromised. Moreover, results of long-term monitoring of CSFV NA titers in PCV2-SI pigs with minimized interference by maternally-derived antibodies suggested that serum PCV2 viral loads greater than 102 copies/mL may compromise the efficacy of CSF vaccine. Overall, a conventional pig model was established to demonstrate the impaired efficacy of the subunit PCV2 vaccine and its impact on the CSF vaccine in vaccination-challenge trials. Additionally, the impaired efficacy of the PCV2 vaccine resulted in increased PCV2-SI, eventually leading to compromised the live attenuated CSF vaccine induced NA response in field farm applications.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Chen JY, Wu CM, Liao CM, et al. The impact of porcine circovirus associated diseases on live attenuated classical swine fever vaccine in field farm applications. Vaccine. 2019. PMID: 31500966. doi:10.1016/j.vaccine.2019.08.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。